P16 HEALTH‐RELATED QUALITY OF LIFE FOR FRAIL TRANSPLANT‐INELIGIBLE PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA TREATED WITH DARATUMUMAB, LENALIDOMIDE AND DEXAMETHASONE: SUBGROUP ANALYSIS OF MAIA TRIAL
Facon, T., Plesner, T., Usmani, S., Kumar, S., Bahlis, N., Hulin, C., Orlowski, R., Nahi, H., Mollee, P., Ramasamy, K., Roussel, M., Jaccard, A., Delforge, M., Karlin, L., Arnulf, B., Chari, A., Pei, H., Gupta, N., Kaila, S., Matt, K., Gries, K., Carson, R., Borgsten, F., Weisel, K., Perrot, A.
Published in HemaSphere (09.05.2023)
Published in HemaSphere (09.05.2023)
Get full text
Journal Article
P09 DARATUMUMAB PLUS LENALIDOMIDE AND DEXAMETHASONE (D‐RD) VERSUS LENALIDOMIDE AND DEXAMETHASONE (RD) ALONE IN TRANSPLANT‐INELIGIBLE PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA (NDMM): UPDATED ANALYSIS OF THE PHASE 3 MAIA STUDY
Weisel, K., Kumar, S., Moreau, P., Bahlis, N., Facon, T., Plesner, T., Orlowski, R., Basu, S., Nahi, H., Hulin, C., Quach, H., Goldschmidt, H., O'Dwyer, M., Perrot, A., Venner, C., Raje, N., Tiab, M., Macro, M., Frenzel, L., Leleu, X., Pei, H., Krevvata, M, Carson, R, Borgsten, F., Usmani, S.
Published in HemaSphere (09.05.2023)
Published in HemaSphere (09.05.2023)
Get full text
Journal Article
P936: TIME TO RESPONSE, DURATION OF RESPONSE, AND PATIENT‐REPORTED OUTCOMES WITH DARATUMUMAB PLUS RD VS RD ALONE IN TRANSPLANT‐INELIGIBLE PATIENTS WITH NDMM: SUBGROUP ANALYSIS OF THE PHASE 3 MAIA STUDY
Facon, T., Kumar, S. K., Plesner, T., Moreau, P., Bahlis, N., Goldschmidt, H., O'Dwyer, M., Perrot, A., Venner, C. P., Weisel, K., Mace, J. R., Raje, N., Tiab, M., Macro, M., Frenzel, L., Leleu, X., Pei, H., Borgsten, F., Usmani, S. Z.
Published in HemaSphere (23.06.2022)
Published in HemaSphere (23.06.2022)
Get full text
Journal Article
Daratumumab Plus Lenalidomide and Dexamethasone in Patients with Transplant-Ineligible Newly Diagnosed Multiple Myeloma: Maia Age Subgroup Analysis
Facon, Thierry, Kumar, Shaji K, Weisel, Katja, Usmani, Saad, Moreau, Philippe, Plesner, Torben, Orlowski, Robert Z., Bahlis, Nizar Jacques, Basu, Supratik, Nahi, Hareth, Hulin, Cyrille, Quach, Hang, O'Dwyer, Michael, Perrot, Aurore, Venner, Christopher P., Raje, Noopur, Tiab, Mourad, Macro, Margaret, Frenzel, Laurent, Leleu, Xavier, Pei, Huiling, Carson, Robin, Borgsten, Fredrik, Goldschmidt, Hartmut
Published in BLOOD (15.11.2022)
Published in BLOOD (15.11.2022)
Get full text
Journal Article
Conference Proceeding
Daratumumab Plus Lenalidomide and Dexamethasone (D-Rd) Versus Lenalidomide and Dexamethasone (Rd) in Transplant-Ineligible Patients (Pts) with Newly Diagnosed Multiple Myeloma (NDMM): Clinical Assessment of Key Subgroups of the Phase 3 Maia Study
Moreau, Philippe, Facon, Thierry, Usmani, Saad, Bahlis, Nizar Jacques, Raje, Noopur, Plesner, Torben, Orlowski, Robert Z., Basu, Supratik, Nahi, Hareth, Hulin, Cyrille, Quach, Hang, Goldschmidt, Hartmut, O'Dwyer, Michael, Perrot, Aurore, Venner, Christopher P., Weisel, Katja, Tiab, Mourad, Macro, Margaret, Frenzel, Laurent, Leleu, Xavier, Pei, Huiling, Krevvata, Maria, Carson, Robin, Borgsten, Fredrik, Kumar, Shaji K
Published in BLOOD (15.11.2022)
Published in BLOOD (15.11.2022)
Get full text
Journal Article
Conference Proceeding
Health-Related Quality of Life for Frail Transplant-Ineligible Patients with Newly Diagnosed Multiple Myeloma Treated with Daratumumab, Lenalidomide and Dexamethasone: Subgroup Analysis of MAIA Trial
Perrot, Aurore, Facon, Thierry, Plesner, Torben, Usmani, Saad, Kumar, Shaji K, Bahlis, Nizar Jacques, Hulin, Cyrille, Orlowski, Robert Z., Nahi, Hareth, Mollee, Peter, Ramasamy, Karthik, Roussel, Murielle, Jaccard, Arnaud, Delforge, Michel, Karlin, Lionel, Arnulf, Bertrand, Chari, Ajai, Pei, Huiling, Gupta, Niodita, Kaila, Shuchita, Matt, Kathryn, Gries, Katharine S., Carson, Robin, Borgsten, Fredrik, Weisel, Katja
Published in BLOOD (15.11.2022)
Published in BLOOD (15.11.2022)
Get full text
Journal Article
Conference Proceeding
Daratumumab Plus Lenalidomide and Dexamethasone (D-Rd) Versus Lenalidomide and Dexamethasone (Rd) Alone in Transplant-Ineligible Patients with Newly Diagnosed Multiple Myeloma (NDMM): Updated Analysis of the Phase 3 Maia Study
Kumar, Shaji K, Moreau, Philippe, Bahlis, Nizar Jacques, Facon, Thierry, Plesner, Torben, Orlowski, Robert Z., Basu, Supratik, Nahi, Hareth, Hulin, Cyrille, Quach, Hang, Goldschmidt, Hartmut, O'Dwyer, Michael, Perrot, Aurore, Venner, Christopher P., Weisel, Katja, Raje, Noopur, Tiab, Mourad, Macro, Margaret, Frenzel, Laurent, Leleu, Xavier, Pei, Huiling, Krevvata, Maria, Carson, Robin, Borgsten, Fredrik, Usmani, Saad
Published in BLOOD (15.11.2022)
Published in BLOOD (15.11.2022)
Get full text
Journal Article
Conference Proceeding
Healthcare resource utilisation and sickness absence in newly diagnosed multiple myeloma patients who did not undergo autologous stem cell transplantation: Trends in Sweden with the changing treatment landscape
Borgsten, Fredrik, Gatopoulou, Xenia, Pisini, Marta, Tambour, Magnus, Schain, Frida, Jones, Christina V., Kwok, Kelvin Ho Man, Batyrbekova, Nurgul, Björkholm, Magnus
Published in European journal of haematology (01.07.2021)
Published in European journal of haematology (01.07.2021)
Get full text
Journal Article
Real-word data on autologous stem cell transplantation in older patients with multiple myeloma
Schain, Frida, Dominicus, Annica, Borgsten, Fredrik, Mozart, Marlene, Björkholm, Magnus
Published in Annals of hematology (01.02.2020)
Published in Annals of hematology (01.02.2020)
Get full text
Journal Article
Plain language summary of the MAIA study of daratumumab plus lenalidomide and dexamethasone for the treatment of people with newly diagnosed multiple myeloma
Facon, Thierry, Kumar, Shaji K, Plesner, Torben, Orlowski, Robert Z, Moreau, Philippe, Bahlis, Nizar, Basu, Supratik, Nahi, Hareth, Hulin, Cyrille, Quach, Hang, Goldschmidt, Hartmut, Perrot, Aurore, Weisel, Katja, Raje, Noopur, Macro, Margaret, Frenzel, Laurent, Leleu, Xavier, Wang, Jianping, Rampelbergh, Rian Van, Uhlar, Clarissa M, Vermeulen, Jessica, Duran, Joana, Borgsten, Fredrik, Usmani, Saad Z
Published in Future oncology (London, England) (01.04.2023)
Published in Future oncology (London, England) (01.04.2023)
Get full text
Journal Article
Daratumumab plus Lenalidomide/ dexamethasone in transplant-neligible patients with newly diagnosed multiple myeloma: MAIA update
Basu, S, Kumar, SK, Moreau, P, Bahlis, N, Facon, T, Plesner, T, Orlowski, RZ, Nahi, H, Hulin, C, Quach, H, Goldschmidt, H, O'Dwyer, M, Perrot, A, Venner, CP, Weisel, K, Raje, N, Tiab, M, Macro, M, Frenzel, L, Leleu, X, Pei, HL, Krevvata, M, Borgsten, F, Usmani, SZ
Published in BRITISH JOURNAL OF HAEMATOLOGY (2023)
Get full text
Published in BRITISH JOURNAL OF HAEMATOLOGY (2023)
Conference Proceeding
Patient-reported outcomes with daratumumab, lenalidomide, and dexamethasone in frail transplant-ineligible patients from MAIA
Ramasamy, K, Facon, T, Plesner, T, Usmani, S, Kumar, S, Bahlis, N, Hulin, C, Orlowski, R, Nahi, H, Mollee, P, Perrott, A, Jaccard, A, Delforge, M, Karlin, L, Arnulf, B, Chari, A, Pei, H, Gupta, N, Kaila, S, Matt, K, Gries, K, Carson, R, Borgsten, F, Weisel, K
Published in BRITISH JOURNAL OF HAEMATOLOGY (2023)
Get full text
Published in BRITISH JOURNAL OF HAEMATOLOGY (2023)
Conference Proceeding